These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 11771952

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Cytokines activate caspase-3 in insulinoma cells of diabetes-prone NOD mice directly and via upregulation of Fas.
    Augstein P, Bahr J, Wachlin G, Heinke P, Berg S, Salzsieder E, Harrison LC.
    J Autoimmun; 2004 Dec; 23(4):301-9. PubMed ID: 15571924
    [Abstract] [Full Text] [Related]

  • 24. Prevention of recurrent but not spontaneous autoimmune diabetes by transplanted NOD islets adenovirally transduced with immunomodulating molecules.
    Sakata M, Yasuda H, Moriyama H, Yamada K, Kotani R, Kurohara M, Okumachi Y, Kishi M, Arai T, Hara K, Hamada H, Yokono K, Nagata M.
    Diabetes Res Clin Pract; 2008 Jun; 80(3):352-9. PubMed ID: 18400329
    [Abstract] [Full Text] [Related]

  • 25. Early events in islets and pancreatic lymph nodes in autoimmune diabetes.
    Aspord C, Rome S, Thivolet C.
    J Autoimmun; 2004 Aug; 23(1):27-35. PubMed ID: 15236750
    [Abstract] [Full Text] [Related]

  • 26. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.
    Ansari MJ, Fiorina P, Dada S, Guleria I, Ueno T, Yuan X, Trikudanathan S, Smith RN, Freeman G, Sayegh MH.
    Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619
    [Abstract] [Full Text] [Related]

  • 27. IL-10-deficiency unmasks unique immune system defects and reveals differential regulation of organ-specific autoimmunity in non-obese diabetic mice.
    Rajagopalan G, Kudva YC, Sen MM, Marietta EV, Murali N, Nath K, Moore J, David CS.
    Cytokine; 2006 Apr; 34(1-2):85-95. PubMed ID: 16740391
    [Abstract] [Full Text] [Related]

  • 28. Exacerbated Th2-mediated airway inflammation and hyperresponsiveness in autoimmune diabetes-prone NOD mice: a critical role for CD1d-dependent NKT cells.
    Araujo LM, Lefort J, Nahori MA, Diem S, Zhu R, Dy M, Leite-de-Moraes MC, Bach JF, Vargaftig BB, Herbelin A.
    Eur J Immunol; 2004 Feb; 34(2):327-35. PubMed ID: 14768037
    [Abstract] [Full Text] [Related]

  • 29. Reduced nitric oxide synthase and cyclo-oxygenase activity in the uterus of non-obese diabetic mice.
    Roca V, Larocca L, Calafat M, Aisemberg J, Meiss R, Franchi AM, Leirós CP.
    Reproduction; 2006 Dec; 132(6):931-8. PubMed ID: 17127753
    [Abstract] [Full Text] [Related]

  • 30. [Mechanisms of human glutamic acid decarboxylase 65 DNA vaccine preventing diabetes in non-obese diabetic mice].
    Luo JH, Zhou ZG, Jiang TJ, Pei JH, Li X, He L, Sun SG.
    Zhonghua Yi Xue Za Zhi; 2004 Nov 02; 84(21):1791-5. PubMed ID: 15631776
    [Abstract] [Full Text] [Related]

  • 31. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
    Piccirillo CA, Tritt M, Sgouroudis E, Albanese A, Pyzik M, Hay V.
    Ann N Y Acad Sci; 2005 Jun 02; 1051():72-87. PubMed ID: 16126946
    [Abstract] [Full Text] [Related]

  • 32. Transient chemokine receptor blockade does not prevent, but may accelerate type 1 diabetes in prediabetic NOD mice.
    Seifarth C, Mack M, Steinlicht S, Hahn EG, Lohmann T.
    Horm Metab Res; 2006 Mar 02; 38(3):167-71. PubMed ID: 16673207
    [Abstract] [Full Text] [Related]

  • 33. Increased sensitivity of prediabetic nonobese diabetic mouse to the behavioral effects of IL-1.
    Bluth, Jafarian-Tehrani M, Michaud B, Haour F, Dantzer R, Homo-Delarche F.
    Brain Behav Immun; 1999 Dec 02; 13(4):303-14. PubMed ID: 10600218
    [Abstract] [Full Text] [Related]

  • 34. Differential glycosylation of interleukin 2, the molecular basis for the NOD Idd3 type 1 diabetes gene?
    Podolin PL, Wilusz MB, Cubbon RM, Pajvani U, Lord CJ, Todd JA, Peterson LB, Wicker LS, Lyons PA.
    Cytokine; 2000 May 02; 12(5):477-82. PubMed ID: 10857762
    [Abstract] [Full Text] [Related]

  • 35. Cytokine balance and lipid antigen presentation in the NOD mouse pancreas during development of insulitis.
    Teros T, Hakala R, Ylinen L, Liukas A, Arvilommi P, Sainio-Pöllänen S, Veräjänkorva E, Pöllänen P, Simell O.
    Pancreas; 2000 Mar 02; 20(2):191-6. PubMed ID: 10707936
    [Abstract] [Full Text] [Related]

  • 36. Cytokines and autoimmune beta cell destruction in NOD mouse fetal pancreas isografts in cyclophosphamide-induced diabetes.
    Kovarik J, Faulkner-Jones BE, Koulmanda M, Mandel TE.
    Autoimmunity; 1997 Mar 02; 26(4):245-52. PubMed ID: 9543185
    [Abstract] [Full Text] [Related]

  • 37. [Labelling of interleukin 2 with 123 iodine and its administration to animals susceptible to diabetes for the visualization of lymphocytic infiltration in the pancreas].
    Signore A, Beverley PC, Negri M, Pozzilli P.
    Minerva Endocrinol; 1988 Mar 02; 13(4):279-85. PubMed ID: 3265983
    [No Abstract] [Full Text] [Related]

  • 38. Systemic biodistribution of radioiodinated interleukin-2 in the rat.
    Gennuso R, Spigelman MK, Vallabhajosula S, Moore F, Zappulla RA, Nieves J, Strauchen JA, Paciucci PA, Malis LI, Goldsmith SJ.
    J Biol Response Mod; 1989 Aug 02; 8(4):375-84. PubMed ID: 2787837
    [Abstract] [Full Text] [Related]

  • 39. Detection of activated lymphocytes in endocrine pancreas of BB/W rats by injection of 123I-interleukin-2: an early sign of type 1 diabetes.
    Signore A, Parman A, Pozzilli P, Andreani D, Beverley PC.
    Lancet; 1987 Sep 05; 2(8558):537-40. PubMed ID: 2887834
    [Abstract] [Full Text] [Related]

  • 40. Pharmacokinetic investigation with 125I labeled T-actemodulin (TAM).
    Petkova I, Koparanova O, Kemileva Z, Milanov S.
    Acta Physiol Pharmacol Bulg; 1993 Sep 05; 19(3):61-5. PubMed ID: 8203274
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.